🇺🇸 FDA
Patent

US 8916538

Solid forms of a thiophosphoramidate nucleotide prodrug

granted A61KA61K31/7056A61K31/706

Quick answer

US patent 8916538 (Solid forms of a thiophosphoramidate nucleotide prodrug) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/7056, A61K31/706, A61K31/7064, A61K31/7068